Macugen (pegaptanib sodium), a novel ocular therapeutic that targets vascular endothelial growth factor (VEGF)

Barrett Katz, Mauro Goldbaum

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Macugen (pegaptanib sodium), a novel ocular therapeutic that targets vascular endothelial growth factor (VEGF)'. Together they form a unique fingerprint.